invIOs

Vienna, Austria

invIOs is a private biotech company that specializes in the discovery and development of next-generation cancer therapies.

$8.9M raised

Oct 2024

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has invIOs raised?

invIOs has raised $8.9M in total funding. The most recent round was Series A. The last funding was announced in October 2024.

Who are invIOs's investors?

invIOs's investors include Ligand Pharmaceuticals, The Austrian Research Promotion Agency (FFG).

Where is invIOs headquartered?

invIOs is headquartered in Vienna, Austria.

What does invIOs do?

invIOs is a private biotech company that specializes in the discovery and development of next-generation cancer therapies.

What stage is invIOs at?

invIOs is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 15, 2024.

MLA

"invIOs — Funding & Investors." VCBacked, October 15, 2024, https://www.vcbacked.co/company/invios. Accessed July 1, 2026.

APA

VCBacked. (2024). invIOs — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/invios

Wikipedia (cite web)

{{cite web |title=invIOs — Funding & Investors |url=https://www.vcbacked.co/company/invios |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 15, 2024.